US$ 24.01
glp-1 receptor agonists and cardiovascular outcome trials an update outcomes in major with The Paper of The Month
Description
Maternal body mass index, gestational weight gain, and the risk of overweight and obesity across childhood: An individual participant data meta-analysis

39 GLP-1RAs and Coronary Artery Disease Epicardial CAD is commonly seen in HFpEF

This conclusion should not be overlooked as a distraction factor with small sample size

JG is supported by the Wellcome Trust Leicestershire Healthcare Inequalities Improvement Doctoral Training Programme (223512/Z/21/Z)
All GLP 1 medications with a rodent C-cell tumor signal carry a boxed warning about potential thyroid C-cell tumor risk

Therapie 67, 539543
